FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents.
Guidi L, Felice C, Procoli A, Bonanno G, Martinelli E, Marzo M, Mocci G, Pugliese D, Andrisani G, Danese S, De Vitis I, Papa A, Armuzzi A, Rutella S.
Guidi L, et al. Among authors: mocci g.
Biomed Res Int. 2013;2013:286368. doi: 10.1155/2013/286368. Epub 2013 Aug 26.
Biomed Res Int. 2013.
PMID: 24063002
Free PMC article.